Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-08-004565
Filing Date
2008-03-12
Accepted
2008-03-12 06:01:42
Documents
12
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a38844e10vk.htm 10-K 2012807
2 EXHIBIT 10.28 a38844exv10w28.htm EX-10.28 95601
3 EXHIBIT 10.29 a38844exv10w29.htm EX-10.29 103040
4 EXHIBIT 10.30 a38844exv10w30.htm EX-10.30 101518
5 EXHIBIT 10.31 a38844exv10w31.htm EX-10.31 22631
6 EXHIBIT 10.32 a38844exv10w32.htm EX-10.32 56411
7 EXHIBIT 23.1 a38844exv23w1.htm EX-23.1 1424
8 EXHIBIT 31.1 a38844exv31w1.htm EX-31.1 8740
9 EXHIBIT 31.2 a38844exv31w2.htm EX-31.2 8704
10 EXHIBIT 32.1 a38844exv32w1.htm EX-32.1 7394
11 GRAPHIC a38844a3884403.gif GRAPHIC 6044
12 GRAPHIC a38844a3884401.gif GRAPHIC 16059
  Complete submission text file 0000950134-08-004565.txt   2450478
Mailing Address 3721 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3721 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 (858) 480-0400
Somaxon Pharmaceuticals, Inc. (Filer) CIK: 0001339455 (see all company filings)

EIN.: 200161599 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51665 | Film No.: 08682282
SIC: 2834 Pharmaceutical Preparations